Читать книгу Clinical Obesity in Adults and Children - Группа авторов - Страница 3

1 Chapter 2Table 2.1 Select sources of data on trends in obesity for the United States ...Table 2.2 Cut‐offs for defining excess body fat using anthropometric measure...Table 2.3 Prevalence of obesity in adults by region and sex, 2016

2 Chapter 4Table 4.1 Pleiotropic genetic obesity syndromesTable 4.2 Monogenic obesity syndromes affecting the leptin‐melanocortin path...

3 Chapter 7Table 7.1 Obesogenic built environment features as assessed by the Spotlight...Table 7.2 Association of built environment features related to physical acti...

4 Chapter 8Table 8.1 Variables identified in the obesity systems map organized by doma...

5 Chapter 10Table 10.1 Adipokines, the effects on their target organs and the net effect...Table 10.2 IDF consensus on waist circumference cut‐off for different ethnic...Table 10.3 Clinically usable parameters to estimate VAT.

6 Chapter 12Table 12.1 Maternal and offspring complications of obesity

7 Chapter 13Table 13.1 Studies of the independent association of MAFLD, including previo...Table 13.2 Efficacy of sodium‐glucose cotransporter 2 (SGLT2) inhibitors in ...Table 13.3 Efficacy of glucagon‐like peptide 1 (GLP1) receptor agonists in p...

8 Chapter 14Table 14.1 Risk pathways that may explain links between excess adiposity and...Table 14.2 A summary of key pieces of evidence from epidemiology, genetics, ...

9 Chapter 15Table 15.1 Definitions in sleep‐disordered breathingTable 15.2 Sleepiness in the patients with obesityTable 15.3 Symptoms of sleep‐disordered breathing

10 Chapter 17Table 17.1 Classification of overweight and obesity in adults and the cut‐of...Table 17.2 Benefits of 5–10% weight loss (Ref)Table 17.3 Goals of obesity managementTable 17.4 Treatment modalities for obesityTable 17.5 Practical approach to obesity treatment – clinical assessment and...Table 17.6 Essential elements for the management of overweight and obesityTable 17.A.1 Clinical history of a person with obesity – key pointsTable 17.A.2 Drug treatment which may be associated with weight gainTable 17.A.3 Measures that can be taken at home

11 Chapter 18Table 18.1 Recommendations and clinical guidelines for the management of obe...

12 Chapter 19Table 19.1 FDA‐approved anti‐obesity medications for chronic weight manageme...

13 Chapter 20Table 20.1 Studies showing the impact of exercise duration on weight loss re...Table 20.2 Studies showing the impact of exercise EE on weight loss response...

14 Chapter 21Table 21.1 Principles of prescribing in obesity [12,17].

15 Chapter 22Table 22.1 Results from a systematic review of reports of bariatric procedur...Table 22.2 Studies of survival benefits of weight loss surgery

16 Chapter 23Table 23.1 Commonly reported weight loss maintenance definitionsTable 23.2 Characteristics of successful weight loss maintainers

17 Chapter 24Table 24.1 Provider training organizations and education organizations invol...Table 24.2 Obesity Medicine Education Collaborative core domains and associa...

18 Chapter 27Table 27.1 Evidence‐based behaviorsTable 27.2 Likely but unproven benefit, low harm behaviorsTable 27.3 Treatment intensity and BMI reduction in randomized controlled tr...Table 27.4 Bariatric surgery eligibility critiera [88].

19 Chapter 28Table 28.1 Interventions recommended by WHO in 2013

20 Chapter 30Table 30.1 Types of taxesTable 30.2 The case of Mexico

21 Chapter 31Table 31.1 Criteria for a whole of systems approach, related systems dynamic...